Tenaya Therapeutics presents new RIDGE-1 trial results showing arrhythmia reduction in PKP2-associated ARVC

Traders Union
All News
Companies
Tenaya RIDGE-1 trial shows progress

Editors' Picks

Crypto News

Financial News

Market Voices

Billionaires

Companies

Broker News

Regulators News

15.05.2026

Tenaya Therapeutics presents new RIDGE-1 trial results showing arrhythmia reduction in PKP2-associated ARVC — Tenaya RIDGE-1 trial shows progress

Tenaya Therapeutics unveiled interim results from its RIDGE-1 Phase 1b/2 trial at #ASGCT, indicating consistent reductions in arrhythmias among adults with PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC).

The data relate to the investigational gene therapy candidate TN-401, which aims to address inherited arrhythmia syndromes. Further details about the trial and findings are available on the company’s official website.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Tenaya Therapeutics previously announced plans to present new clinical data from the RIDGE-1 TN-401 trial during a late breaking session at ASGCT, according to a company statement earlier this year. Separately, Tenaya also recognized Eugene Braunwald for his contributions to hypertrophic cardiomyopathy and modern cardiology at a recent event. The company continues to advance research in inherited cardiac conditions.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Trading thin air: Why Binance is closing its NFT marketplace

By Oleg Tkachenko
15 hours ago

Trading thin air: Why Binance is closing its NFT marketplace

Editors' Picks

Bitcoin without investors: Why IPOs are winning attention

By Eugene Komchuk
Yesterday

Bitcoin without investors: Why IPOs are winning attention

Editors' Picks

Bitcoin price prediction based on MACD: Bearish momentum gains strength

By Anastasiia Chabaniuk
02.06.2026

Bitcoin price prediction based on MACD: Bearish momentum gains strength

Editors' Picks

All Editors' Top Picks

Latest Tenaya News

Tenaya Therapeutics sees advances in symptom relief and cardiac hypertrophy measures

By Andreas Kristo
Yesterday

Tenaya Therapeutics sees advances in symptom relief and cardiac hypertrophy measures

Companies

Tenaya Therapeutics CEO to present at Jefferies Global Healthcare Conference on June 4

By Eugene Komchuk
29.05.2026

Tenaya Therapeutics CEO to present at Jefferies Global Healthcare Conference on June 4

Companies

Tenaya Therapeutics partners on parent attitudes survey for gene therapy in pediatric cardiomyopathy

By Eugene Komchuk
13.05.2026

Tenaya Therapeutics partners on parent attitudes survey for gene therapy in pediatric cardiomyopathy

Companies

All Tenaya News

Oleg Tkachenko
15 hours ago

Trading thin air: Why Binance is closing its NFT marketplace

Eugene Komchuk
Yesterday

Bitcoin without investors: Why IPOs are winning attention

Anastasiia Chabaniuk
02.06.2026

Bitcoin price prediction based on MACD: Bearish momentum gains strength

Kyle Torpey
01.06.2026

Ethereum's identity crisis: Between Wall Street and cypherpunk

Eugene Komchuk
01.06.2026

Europe and U.S. prepare crypto taxes: How their approaches differ

Andrey Mastykin
17 min ago

Gold miners have moved from resistance to support, Otavio (Tavi) Costa notes

Daria Chernytska
17 min ago

Scott Melker: JPMorgan, Citi and major U.S. banks plan tokenized deposit network

Daria Chernytska
32 min ago

Dan Held: Digital gold narrative most valuable for 15 years

Eugene Komchuk
1 hour ago

Chris Perruna: RDDT climbs 44 percent from March lows, nears 200-day moving average

Hlib Chabaniuk
1 hour ago

Peter Tuchman: Dow Jones closes at record high as excitement builds

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Olga Shendetskaya
13 hours ago

Coinbase launches SpaceX pre-IPO futures

Coinbase launches SpaceX pre-IPO futures

Igor Krasulya
13 hours ago

S&P 500 futures fall as Iran tensions snap 9-day winning streak

S&P 500 futures fall as Iran tensions snap 9-day winning streak

Ivan Andriyenko
14 hours ago

SpaceX IPO could lift Elon Musk's net worth above $1 trillion

SpaceX IPO could lift Elon Musk's net worth above $1 trillion

Anastasiia Chabaniuk
15 hours ago

Coinbase freezes $3M as U.S. targets Southeast Asia scam rings

Coinbase freezes $3M as U.S. targets Southeast Asia scam rings

Olga Shendetskaya
16 hours ago

Oil falls as Israel-Lebanon ceasefire eases Gulf risk

Oil falls as Israel-Lebanon ceasefire eases Gulf risk

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Alphabet declines amid $80 billion share issuance and AI investments

Anton Kharitonov
Now

Microsoft remains under pressure despite AI breakthroughs

Anton Kharitonov
Now

Apple pulls back after reaching new highs

Anton Kharitonov
Now

Bitcoin remains under pressure as market awaits new source of demand

Dmytro Kharkov
Now

AMD faces pullback risk as technology sector weakens

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.